Seoul, South Korea * June 11-14, 2026 Poster A-0294 Retrograde Ureteral Dosing in Nonhuman Primates for Drug Delivery to the Kidney

Suwon, South Korea * May 29, 2026   " A New Nonhuman Primate Preclinical Model of Dry Age-Related Macular Degeneration "   Session 3-1, 2:30-3:00 PM

San Diego, CA June 22-25, 2026

We hereby announce that our subsidiaries, CMIC Pharma Science Co., Ltd. (Head Office: Hokuto City, Yamanashi Prefecture; President & CEO: Takahiro Natsume; hereinafter “CMIC Pharma Science”) and Hamamatsu Pharma Research, Inc. (Head Office: Hamamatsu City, Shizuoka Prefecture; President: Takahiro Natsume; hereinafter “Hamamatsu Pharma Research”) will be integrated through an absorption-type merger, with CMIC Pharma Science as the surviving company and Hamamatsu Pharma Researc